Top Buy
Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
Agilent Technologies Inc. | 17 | 3 | 1 | 1 | €128.20 | €133.66 | 4.260% |
Novo Nordisk A/S ADR | 17 | 1 | 2 | 0 | €112.00 | €130.00 | 16.071% |
Exelixis Inc. | 17 | 0 | 2 | 0 | €20.62 | €25.64 | 24.322% |
Dexcom Inc. | 18 | 0 | 3 | 0 | €117.64 | €136.82 | 16.306% |
Sutro Biopharma Inc | 18 | 0 | 4 | 0 | €3.42 | €11.05 | 223.053% |
United Therapeutics | 18 | 0 | 3 | 0 | €240.90 | €288.66 | 19.826% |
Icon plc | 18 | 0 | 6 | 0 | €280.90 | €318.99 | 13.562% |
Resmed Inc. | 19 | 0 | 3 | 0 | €202.90 | €207.72 | 2.373% |
Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €11.99 | €22.78 | 89.952% |
R1 RCM Inc. | 19 | 0 | 2 | 0 | €11.40 | €17.21 | 50.988% |
BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €78.12 | €102.62 | 31.361% |
Jazz Pharmaceuticals plc | 21 | 0 | 2 | 0 | €101.95 | €184.14 | 80.618% |
AbbVie Inc. | 21 | 0 | 4 | 0 | €150.20 | €174.43 | 16.134% |
Amgen Inc. | 21 | 0 | 3 | 0 | €294.40 | €294.28 | -0.040% |
Zoetis Inc. A | 21 | 1 | 3 | 1 | €155.36 | €200.06 | 28.770% |
TG Therapeutics Inc. | 22 | 4 | 5 | 0 | €15.64 | €28.06 | 79.441% |
Trinity Biotech ADR | 22 | 0 | 1 | 0 | €0.41 | - | - |
HCA Holdings Inc. | 22 | 0 | 6 | 0 | €287.90 | €294.53 | 2.301% |
Humana Inc. | 23 | 0 | 5 | 0 | €299.30 | €439.88 | 46.968% |
Stryker Corp. | 23 | 0 | 10 | 0 | €305.90 | €335.03 | 9.522% |
Intra-Cellular Therapies Inc. | 23 | 0 | 8 | 0 | €66.00 | €79.43 | 20.348% |
Cytokinetics Inc. | 24 | 1 | 3 | 0 | €61.00 | €83.81 | 37.401% |
Edwards Lifesciences Corp. | 25 | 1 | 3 | 0 | €79.91 | €87.48 | 9.467% |
Thermo Fisher Scientific Inc. | 27 | 0 | 6 | 0 | €530.40 | €568.09 | 7.107% |
Neurocrine Bioscience | 27 | 0 | 7 | 0 | €130.40 | €140.34 | 7.623% |